Scutellarin protects cortical neurons against neonatal hypoxic‐ischemic encephalopathy injury via upregulation of vascular endothelial growth factor
Abstract Neonatal hypoxic‐ischemic encephalopathy (NHIE) causes devastating cerebral damage and neurological deficits that seldom have effective therapies. This study aimed to explore the mechanisms underlying the therapeutic efficacy of Scutellarin in NHIE. NHIE models were successfully established...
Main Authors: | Yu Zou, Chang‐Le Fang, Ya‐Ting Wang, Hua Li, Xi‐Liang Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2022-09-01
|
Series: | Ibrain |
Subjects: | |
Online Access: | https://doi.org/10.1002/ibra.12052 |
Similar Items
-
Outcome Prediction Rule for Neonatal Hypoxic-Ischemic Encephalopathy
by: J Gordon Millichap
Published: (2006-08-01) -
Thiamine as a Possible Neuroprotective Strategy in Neonatal Hypoxic-Ischemic Encephalopathy
by: Gian Pietro Sechi, et al.
Published: (2021-12-01) -
Neuroprotective treatment options for neonatal hypoxic-ischemic encephalopathy: Therapeutic hypothermia and beyond
by: Merih Cetinkaya
Published: (2024-09-01) -
Comparative Efficacy and Safety of Neuroprotective Therapies for Neonates With Hypoxic Ischemic Encephalopathy: A Network Meta-Analysis
by: Clare Yuen Zen Lee, et al.
Published: (2019-10-01) -
Evaluation of the role of ischemia modified albumin in neonatal hypoxic-ischemic encephalopathy
by: Mohamed A. Talat, et al.
Published: (2020-08-01)